Structure Therapeutics (GPCR) outlook: aleniglipron obesity data de-risks lead asset, amylin adds upside, cash strong—see ...

CAT bonds, or catastrophe bonds, could bring data center risk to capital markets, with the first dedicated deal potentially ...

Mega AI data centers with up to $50B replacement costs are reshaping physical-risk insurance, driving premiums toward $200B ...

Structure Therapeutics’ oral GLP-1 candidate aleniglipron showed 72-week efficacy “in line” with Novo Nordisk’s oral Wegovy, ...

The data center is expected to become partially operational near the end of 2026. The Forum was the first media outlet inside ...

With data centers linked to rising energy bills and pollution, Cuban says towns should lock down protections, public returns ...

Human spatial representations are often assumed to represent Euclidean properties such as length, distance, and angle. Here we test an alternative (but not mutually exclusive) possibility – that ...

Vantage Data Centers is seeking $2 billion in loans from Pimco and PGIM, adding to nearly $10 billion in recent debt ...

Structure Therapeutics Inc. ( GPCR) reported positive clinical data from its two lead oral small-molecule programs, ACCG-2671, an investigational dual amylin and calcitonin receptor agonist, and ...

Blue Owl is considering a public data center REIT seeded with about $6.5B of assets as AI infrastructure spending draws more ...

Structure Therapeutics Inc. GPCR on Tuesday announced encouraging clinical trial findings for two of its main oral drug ...

Meta's $17.1 billion settlement over youth addiction claims falls short, leaving data collection and targeted ads intact, ...